facebook-page-view
Advertisement

Taro Pharma

Premium
M&A down 30%, PE deals down 20% in Q3

General

04 October, 2012

M&A down 30%, PE deals down 20% in Q3

Even as deal making gathered momentum over the last two quarters this calendar year, both private equity and M&A deals ......

Premium
Sun Pharma to buy remaining 34% of Taro for $592M

Healthcare

05 September, 2012

Sun Pharma to buy remaining 34% of Taro for $592M

Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has reached an agreement to buy out the minority ......